This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Monika Schaefer-Korting: Innovator in Antiandrogenic Treatments
Introduction
Monika Schaefer-Korting is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of dermatology, particularly in the development of treatments for conditions related to hair growth and skin health. With a focus on innovative formulations, her work has the potential to impact many individuals suffering from androgenic alopecia and other related conditions.
Latest Patents
Monika Schaefer-Korting holds a patent for "Preparations for topical administration of substances having antiandrogenic activity." This preparation includes at least one form of lipid nanoparticles or a nanoemulsion containing compounds that are effective in treating androgenic alopecia, hirsutism, seborrhea, and acne. The formulation is designed to prevent unwanted hair growth and can also be utilized in cosmetic applications.
Career Highlights
Throughout her career, Monika has worked with notable companies in the pharmaceutical industry, including Aventis Pharma Deutschland GmbH and Aventis Pharma S.A. Her experience in these organizations has allowed her to develop and refine her innovative approaches to dermatological treatments.
Collaborations
Monika has collaborated with esteemed colleagues such as Karl Theodor Kraemer and Karl-Heinz Nietsch. These partnerships have contributed to her success and the advancement of her research in the field.
Conclusion
Monika Schaefer-Korting is a trailblazer in the development of antiandrogenic treatments, with a patent that showcases her innovative approach to addressing dermatological issues. Her work continues to influence the field and offers hope for many individuals seeking effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
